#ASCO_2025 hashtag - Bluesky

@newsen.bsky.social

6 months ago

Canopy's Remote Therapeutic Monitoring to Transform Oncology Care at ASCO 2025 Canopy will showcase innovative findings on its Remote Therapeutic Monitoring platform at ASCO 2025, aiming to enhance care for oncology patients receiving oral medications.

Canopy's Remote Therapeutic Monitoring to Transform Oncology Care at ASCO 2025 #United_States #Chicago #oncology #ASCO_2025 #Canopy

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

7 months ago

HopeAI Revolutionizes Cancer Drug Trials Using AI-Generated Synthetic Data at ASCO 2025 HopeAI showcases its innovative application of AI-generated synthetic data to enhance the efficiency of cancer drug trials at ASCO 2025.

HopeAI Revolutionizes Cancer Drug Trials Using AI-Generated Synthetic Data at ASCO 2025 #United_States #New_York #Cancer_Trials #ASCO_2025 #HopeAI

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago

Hengrui Pharma's Groundbreaking Contributions at 2025 ASCO Conference: A Showcase of Cancer Innovations At the 2025 ASCO Annual Meeting, Hengrui Pharma presented groundbreaking research findings that assess their innovative cancer treatments' efficacy in various oncology fields.

Hengrui Pharma's Groundbreaking Contributions at 2025 ASCO Conference: A Showcase of Cancer Innovations #China #Shanghai #Hengrui_Pharma #ASCO_2025 #Cancer_Innovation

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago

Exciting Advances in Cancer Treatment Shared at 2025 ASCO Annual Meeting The 2025 ASCO Annual Meeting showcased promising data from clinical trials on ADC candidates from Duality Bio, enhancing cancer treatment options.

Exciting Advances in Cancer Treatment Shared at 2025 ASCO Annual Meeting #USA #Chicago #ASCO_2025 #Duality_Bio #ADC_Candidates

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago

Promising Phase 1 Data on EBC-129 Presented at ASCO 2025 The Experimental Drug Development Centre revealed significant new data for antibody-drug conjugate EBC-129 targeting pancreatic cancer at ASCO 2025.

Promising Phase 1 Data on EBC-129 Presented at ASCO 2025 #Singapore #pancreatic_cancer #ASCO_2025 #EBC-129

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago

Innovent Biologics Shares Promising Phase 1 Results for IBI343 in Pancreatic Cancer Treatment at ASCO 2025 At ASCO 2025, Innovent Biologics presented updated Phase 1 trial data on IBI343, showing promising efficacy in patients with advanced pancreatic cancer.

Innovent Biologics Shares Promising Phase 1 Results for IBI343 in Pancreatic Cancer Treatment at ASCO 2025 #China #Suzhou #Innovent_Biologics #IBI343 #ASCO_2025

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago

New Findings on Telehealth Cancer Screening Programs Unveiled at ASCO 2025 Color Health shared groundbreaking research on telehealth cancer screening at ASCO 2025, showing enhanced accessibility and effectiveness for patients.

New Findings on Telehealth Cancer Screening Programs Unveiled at ASCO 2025 #United_States #Chicago #cancer_screening #ASCO_2025 #Color_Health

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago

GV20 Therapeutics Unveils Promising Phase 1 Data on GV20-0251 at ASCO 2025 Annual Meeting GV20 Therapeutics has shared exciting updates on their GV20-0251 antibody in advanced solid tumors, demonstrating promising safety and efficacy.

GV20 Therapeutics Unveils Promising Phase 1 Data on GV20-0251 at ASCO 2025 Annual Meeting #United_States #Newton #ASCO_2025 #GV20_Therapeutics #GV20-0251

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago

TuHURA Biosciences Showcases Promising IFx-Hu2.0 Trial Progress at ASCO 2025 TuHURA Biosciences presented its IFx-Hu2.0 trial poster at ASCO 2025, detailing a novel innate immune agonist for advanced Merkel cell carcinoma.

TuHURA Biosciences Showcases Promising IFx-Hu2.0 Trial Progress at ASCO 2025 #USA #Chicago #ASCO_2025 #TuHURA_Biosciences #IFx-Hu2.0

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago

Innovent Biologics Reveals Promising Data for IBI363 in Colorectal Cancer Treatment at 2025 ASCO Innovent Biologics presents new clinical trial data for its IBI363 treatment at ASCO 2025, showcasing significant survival benefits in advanced colorectal cancer.

Innovent Biologics Reveals Promising Data for IBI363 in Colorectal Cancer Treatment at 2025 ASCO #China #Suzhou #Innovent_Biologics #ASCO_2025 #IBI363

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago

Leads Biolabs Unveils Promising LBL-024 Results at 2025 ASCO Meeting Leads Biolabs presented groundbreaking data on LBL-024 for treating advanced neuroendocrine carcinoma, showcasing impressive results at the 2025 ASCO.

Leads Biolabs Unveils Promising LBL-024 Results at 2025 ASCO Meeting #China #Leads_Biolabs #LBL-024 #Nanjing #ASCO_2025

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago

Myeloid Therapeutics Presents Promising In Vivo mRNA CAR Data at ASCO 2025 Myeloid Therapeutics showcases its innovative mRNA CAR therapies at the 2025 ASCO Annual Meeting, marking significant advancements in cancer treatment.

Myeloid Therapeutics Presents Promising In Vivo mRNA CAR Data at ASCO 2025 #United_States #Chicago #Myeloid_Therapeutics #ASCO_2025 #RNA-based_CAR

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago

ImmunoGenesis Unveils Promising Results for IMGS-001 at ASCO 2025 Meeting At the 2025 ASCO Annual Meeting, ImmunoGenesis will share groundbreaking updates on its clinical study for IMGS-001, a dual-specific antibody aimed at tackling immune-excluded tumors.

ImmunoGenesis Unveils Promising Results for IMGS-001 at ASCO 2025 Meeting #USA #Chicago #ASCO_2025 #ImmunoGenesis #IMGS-001

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago

John Theurer Cancer Center Showcases Groundbreaking Research on Cancer at ASCO 2025 The John Theurer Cancer Center presents exciting cancer research findings at ASCO 2025, exploring new treatments and therapies for various cancers.

John Theurer Cancer Center Showcases Groundbreaking Research on Cancer at ASCO 2025 #USA #Cancer_Research #Hackensack #John_Theurer_Cancer_Center #ASCO_2025

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago

Florida Cancer Specialists Showcases Innovative Cancer Research at ASCO 2025 Florida Cancer Specialists presents groundbreaking cancer research findings at ASCO 2025. The studies aim to revolutionize oncology care and advance treatment precision.

Florida Cancer Specialists Showcases Innovative Cancer Research at ASCO 2025 #United_States #Chicago #Cancer_Research #Florida_Cancer_Specialists #ASCO_2025

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago

Grit Biotechnology Unveils Cutting-Edge Clinical Developments at 2025 ASCO Conference Grit Biotechnology showcases innovative TIL therapies at the 2025 ASCO Annual Meeting in Chicago, detailing advancements in cancer treatments.

Grit Biotechnology Unveils Cutting-Edge Clinical Developments at 2025 ASCO Conference #China #Shanghai #GRIT_Biotechnology #ASCO_2025 #TIL_therapies

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago

Bexion Pharmaceuticals to Present New Findings at 2025 ASCO Annual Meeting Bexion Pharmaceuticals will showcase two significant abstracts at the ASCO Annual Meeting in Chicago, focusing on their innovative cancer therapy BXQ-350 and its implications.

Bexion Pharmaceuticals to Present New Findings at 2025 ASCO Annual Meeting #USA #Chicago #Bexion_Pharmaceuticals #BXQ-350 #ASCO_2025

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago

OncoHost to Present Groundbreaking Cancer Research at ASCO 2025 Event OncoHost announces that three significant research abstracts will be showcased at ASCO 2025, highlighting advances in precision medicine for various cancers.

OncoHost to Present Groundbreaking Cancer Research at ASCO 2025 Event #United_States #Chicago #Precision_Medicine #OncoHost #ASCO_2025

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago

Canopy's Innovative Remote Monitoring Takes Center Stage at ASCO 2025 Annual Meeting Canopy presents groundbreaking findings at ASCO 2025, showcasing its Remote Therapeutic Monitoring Platform's potential to enhance oncology care.

Canopy's Innovative Remote Monitoring Takes Center Stage at ASCO 2025 Annual Meeting #United_States #Chicago #oncology #ASCO_2025 #Canopy

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago

Menarini Group Highlights Elacestrant's Potential in Combination Therapy for ER+, HER2- Breast Cancer at ASCO 2025 Menarini Group shared promising updates on Elacestrant's effectiveness against ER+, HER2- metastatic breast cancer during ASCO 2025. The results emphasize its potential in combination therapies.

Menarini Group Highlights Elacestrant's Potential in Combination Therapy for ER+, HER2- Breast Cancer at ASCO 2025 #Italy #Menarini #Elacestrant #Florence #ASCO_2025

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago

Menarini Group Unveils Promising Elacestrant Data at ASCO 2025 Annual Meeting Menarini Group showcases updated data on Elacestrant's effectiveness in treating ER+, HER2- metastatic breast cancer, highlighting its potential for combination therapy at ASCO 2025.

Menarini Group Unveils Promising Elacestrant Data at ASCO 2025 Annual Meeting #USA #Elacestrant #Florence #Menarini_Group #ASCO_2025

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago

Upcoming Presentation of Innovative CAR T Therapy at ASCO 2025 by Verismo Therapeutics Verismo Therapeutics will unveil promising updates on the innovative KIR-CAR platform during their poster presentation at ASCO 2025.

Upcoming Presentation of Innovative CAR T Therapy at ASCO 2025 by Verismo Therapeutics #USA #Chicago #Verismo_Therapeutics #ASCO_2025 #KIR-CAR

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago

Groundbreaking Immunotherapy GV20-0251 to be Featured at ASCO 2025 Annual Meeting GV20 Therapeutics is set to present new monotherapy data on GV20-0251, a promising cancer treatment, at ASCO 2025 in Chicago.

Groundbreaking Immunotherapy GV20-0251 to be Featured at ASCO 2025 Annual Meeting #United_States #Chicago #ASCO_2025 #GV20_Therapeutics #GV20-0251

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago

Oncolytics Biotech Unveils Breakthrough Clinical Data on Pelareorep at ASCO 2025 At the ASCO 2025 conference, Oncolytics Biotech Inc. presented significant findings on pelareorep's immune activation capabilities in treating pancreatic cancer.

Oncolytics Biotech Unveils Breakthrough Clinical Data on Pelareorep at ASCO 2025 #USA #San_Diego #Oncolytics_Biotech #pelareorep #ASCO_2025

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago

Menarini Group Showcases Latest Efficacy Data for Elacestrant in Breast Cancer at ASCO 2025 Menarini Group unveiled promising efficacy and safety data for Elacestrant combined with targeted therapies for ER+/HER2- metastatic breast cancer at ASCO 2025.

Menarini Group Showcases Latest Efficacy Data for Elacestrant in Breast Cancer at ASCO 2025 #Italy #Elacestrant #Florence #Menarini_Group #ASCO_2025

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago

Bantam Pharmaceutical Set to Showcase Cancer Treatment Progress at ASCO 2025 Annual Meeting Bantam Pharmaceutical announces its acceptance for presentation at ASCO 2025, showcasing its promising cancer treatment, BTM-3566.

Bantam Pharmaceutical Set to Showcase Cancer Treatment Progress at ASCO 2025 Annual Meeting #United_States #Chicago #ASCO_2025 #Bantam_Pharmaceutical #BTM-3566

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago

Advancements in Cancer Care: RWJBarnabas and Rutgers Institute Showcase Groundbreaking Research at ASCO 2025 RWJBarnabas Health and Rutgers Cancer Institute will reveal innovative cancer research findings during the 2025 ASCO Annual Meeting, reshaping patient care.

Advancements in Cancer Care: RWJBarnabas and Rutgers Institute Showcase Groundbreaking Research at ASCO 2025 #United_States #Rutgers_Cancer_Institute #RWJBarnabas_Health #ASCO_2025 #New_Brunswick,_New_Jersey

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago